ISGylation drives basal breast tumour progression by promoting EGFR recycling and Akt signalling. Bolado-Carrancio A, Lee M, Ewing A, Muir M, et al. Oncogene 2021;40:6235-6247.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bolado-Carrancio A, Lee M, Ewing A, Muir M, et al. ISGylation drives basal breast tumour progression by promoting EGFR recycling and Akt signalling. Oncogene 2021;40:6235-6247.
PMID: 34556814